Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis

NCT00923832 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00923832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00923832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
March 30, 2009
Completion date
November 23, 2009
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

immunocompromised host, invasive pulmonary aspergillosis, invasive pulmonary fungal infection, invasive pulmonary zygomycosis